CSF2RB p.Arg461Cys
c.1381C>T · rs371045078 · VCV1390682
Computational evidence
| Protein change | ||
| AlphaMissense | 0.1866 | likely benign |
|---|---|---|
| REVEL | 0.643 | indeterminate |
| SaProt | LLR -1.78 | tolerated |
| ⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 2.9 | GERP 1.6, phastCons 1 |
| Regional constraint | o/e 0.85 | unconstrained · MANE · 14 kb · p 0.00014 · regional, not allelic |
| Overall | ||
| CADD | 25.3 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| South Asiangrpmax | 0.0966% | 1,035 |
| Remaining individualsnot grpmax-eligible | 0.0256% | 3,907 |
| African / African-American | 0.0147% | 6,822 |
| European (non-Finnish) | 0.00712% | 14,048 |
| Admixed American | 0.00333% | 30,014 |
| East Asian | 0.00223% | 44,886 |
| Finnishnot grpmax-eligible | 0.00156% | 64,022 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CSF2RB
- Protein
- p.Arg461Cys
- Coding
- c.1381C>T
- MANE Select
- NM_000395
- dbSNP
- rs371045078
- Type
- single nucleotide variant
- Location
- chr22:36935416 (GRCh38)
- Gene constraint
- LOEUF 0.511 · pLI 0.93 · ClinGen HI gene assoc. with recessive phenotype (gnomAD)
- Structure
- AlphaFold pLDDT 65.50 · 10 PDB
- Residue 461
- an α-helix
Disease context
surfactant metabolism dysfunction, pulmonary, 5 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Hereditary pulmonary alveolar proteinosis (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Adolescent, Adult, Childhood, Elderly, Infancy
- Prevalence
- <1 / 1 000 000 (Worldwide)
Similar variants
- CSF2RB p.Arg461His Uncertain significance ★★ ⚠ same residue
- CSF2RB p.Arg461= Likely benign ★★ same residue
- CSF2RB p.Arg211Gln Uncertain significance ★★ ⚠ same condition
- CSF2RB p.Glu533Lys Uncertain significance ★★ ⚠ same condition
- CSF2RB p.Gly845Ser Uncertain significance ★★ ⚠ same condition
- CSF2RB p.Thr196Asn Uncertain significance ★★ ⚠ same condition
- CSF2RB p.Thr50Ile Uncertain significance ★★ ⚠ same condition
- CSF2RB p.Arg215His Benign/Likely benign ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/csf2rb-p-arg461cys (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown